Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2539141rdf:typepubmed:Citationlld:pubmed
pubmed-article:2539141lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:2539141lifeskim:mentionsumls-concept:C0012854lld:lifeskim
pubmed-article:2539141lifeskim:mentionsumls-concept:C0012860lld:lifeskim
pubmed-article:2539141lifeskim:mentionsumls-concept:C0033414lld:lifeskim
pubmed-article:2539141lifeskim:mentionsumls-concept:C0078504lld:lifeskim
pubmed-article:2539141lifeskim:mentionsumls-concept:C0205198lld:lifeskim
pubmed-article:2539141pubmed:issue3lld:pubmed
pubmed-article:2539141pubmed:dateCreated1989-5-11lld:pubmed
pubmed-article:2539141pubmed:abstractTextWithangulatin A, a new compound with a known chemical structure and from the antitumor Chinese herb Physalis angulata L, was found to act on topoisomerase II to induce topoisomerase II-mediated DNA damage in vitro. It has two effective dosage ranges of approximate 0.5 and 20 microM, with about one-third the activity of 20 microM VM-26.lld:pubmed
pubmed-article:2539141pubmed:languageenglld:pubmed
pubmed-article:2539141pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2539141pubmed:citationSubsetIMlld:pubmed
pubmed-article:2539141pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2539141pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2539141pubmed:statusMEDLINElld:pubmed
pubmed-article:2539141pubmed:monthMarlld:pubmed
pubmed-article:2539141pubmed:issn0006-291Xlld:pubmed
pubmed-article:2539141pubmed:authorpubmed-author:LinH SHSlld:pubmed
pubmed-article:2539141pubmed:authorpubmed-author:GrinE IEIlld:pubmed
pubmed-article:2539141pubmed:authorpubmed-author:HuangH WHWlld:pubmed
pubmed-article:2539141pubmed:authorpubmed-author:JuangJ KJKlld:pubmed
pubmed-article:2539141pubmed:issnTypePrintlld:pubmed
pubmed-article:2539141pubmed:day31lld:pubmed
pubmed-article:2539141pubmed:volume159lld:pubmed
pubmed-article:2539141pubmed:ownerNLMlld:pubmed
pubmed-article:2539141pubmed:authorsCompleteYlld:pubmed
pubmed-article:2539141pubmed:pagination1128-34lld:pubmed
pubmed-article:2539141pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2539141pubmed:meshHeadingpubmed-meshheading:2539141-...lld:pubmed
pubmed-article:2539141pubmed:meshHeadingpubmed-meshheading:2539141-...lld:pubmed
pubmed-article:2539141pubmed:meshHeadingpubmed-meshheading:2539141-...lld:pubmed
pubmed-article:2539141pubmed:meshHeadingpubmed-meshheading:2539141-...lld:pubmed
pubmed-article:2539141pubmed:meshHeadingpubmed-meshheading:2539141-...lld:pubmed
pubmed-article:2539141pubmed:meshHeadingpubmed-meshheading:2539141-...lld:pubmed
pubmed-article:2539141pubmed:meshHeadingpubmed-meshheading:2539141-...lld:pubmed
pubmed-article:2539141pubmed:meshHeadingpubmed-meshheading:2539141-...lld:pubmed
pubmed-article:2539141pubmed:meshHeadingpubmed-meshheading:2539141-...lld:pubmed
pubmed-article:2539141pubmed:year1989lld:pubmed
pubmed-article:2539141pubmed:articleTitleA new compound, withangulatin A, promotes type II DNA topoisomerase-mediated DNA damage.lld:pubmed
pubmed-article:2539141pubmed:affiliationInstitute of Life Science and National Tsing Hua University, Taiwan, R.O.C.lld:pubmed
pubmed-article:2539141pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2539141pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2539141lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2539141lld:pubmed